{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:41:47Z","timestamp":1790451707109,"version":"4.1.0"},"reference-count":38,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South. Afr. j. HIV med."],"abstract":"<jats:p>Introduction:\u00a0Our systematic scoping review has demonstrated a research gap in antiretroviral treatment (ART) nephrotoxicity as well as in the long-term outcomes of renal function for patients on ART in South Africa. Bearing in mind the high prevalence of human immunodeficiency virus (HIV) in South Africa, this is of great concern.Objectives:\u00a0To determine the risk factors and co-morbidities associated with changes in renal function in HIV-infected adults in South Africa.Methods:\u00a0We conducted a retrospective study of 350 ART-na\u00efve adult patients attending the King Edward VIII HIV clinic, Durban, South Africa. Data were collected at baseline (pre-ART) and at six, 12, 18 and 24 months on ART. Renal function was assessed in the 24-month period using the Modification of Diet in Renal Disease equation and was categorised into normal renal function (estimated glomerular filtration rate [eGFR] \u2265 60), moderate renal impairment (eGFR 30\u201359), severe renal impairment (eGFR 15\u201329) and kidney failure (eGFR &lt; 15 mL\/min\/1.73 m2). Generalised linear models for binary data were used to model the probability of renal impairment over the five time periods, controlling for repeated measures within participants over time. Risk ratios and 95% confidence intervals (CI) were reported for each time point versus baseline.Results:\u00a0The cohort was 64% female, and 99% were Black. The median age was 36 years. At baseline, 10 patients had hypertension (HPT), six had diabetes, 61 were co-infected with tuberculosis (TB) and 157 patients had a high body mass index (BMI) with 25.4% being categorised as overweight and 19.4% as obese. The majority of the patients (59.3%) were normotensive. At baseline, the majority of the patients (90.4%) had normal renal function (95% CI: 86% \u2013 93%), 7.0% (CI: 5% \u2013 10%) had moderate renal impairment, 1.3% (CI: 0% \u2013 3%) had severe renal impairment and 1.3% (CI: 0% \u2013 3%) had renal failure. As BMI increased by one unit, the risk of renal impairment increased by 1.06 (CI: 1.03\u20131.10) times. The association of HPT with abnormal renal function was found to be insignificant,\u00a0p\u00a0&gt; 0.05. The vast majority of patients were initiated on tenofovir disoproxil fumarate (TDF) (90.6%), in combination with lamivudine (3TC) (100%) and either efavirenz (EFV) (56.6%) or nevirapine (NVP) (43.4%).Conclusion:\u00a0This study reports a low prevalence of baseline renal impairment in HIV-infected ART-na\u00efve outpatients. An improvement in renal function after the commencement of ART has been demonstrated in this population. However, the long-term outcomes of patients with HIV-related renal disease are not known.<\/jats:p>","DOI":"10.4102\/sajhivmed.v19i1.770","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T03:01:09Z","timestamp":1523588469000},"source":"Crossref","is-referenced-by-count":8,"title":["Risk factors and co-morbidities associated with changes in renal function among antiretroviral treatment-na\u00efve adults in South Africa: A chart review"],"prefix":"10.4102","volume":"19","author":[{"given":"Shirelle","family":"Assaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tivani P.","family":"Mashamba-Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nombulelo P.","family":"Magula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"key":"ref0001","author":"UNAIDS","year":"2014","journal-title":"The gap report [homepage on the Internet]"},{"key":"ref0002","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035278"},{"key":"ref0003","author":"HIV\/AIDS JUNPo, HIV\/AIDS JUNPo","year":"2014","journal-title":"90-90-90: An ambitious treatment target to help end the AIDS epidemic [homepage on the Internet]"},{"key":"ref0004","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0871-5"},{"key":"ref0005","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8603-5-9"},{"key":"ref0006","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70002-6"},{"key":"ref0007","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/562790"},{"key":"ref0008","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.142"},{"key":"ref0009","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67096.x"},{"key":"ref0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1712-z"},{"key":"ref0011","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.318"},{"issue":"13","key":"ref0012","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0b013e32834957da","volume":"25","author":"Brennan","year":"2011","journal-title":"AIDS (London, England)"},{"key":"ref0013","author":"National Department of Health","year":"2010","journal-title":"South African antiretroviral treatment guidelines 2010 [homepage on the Internet]"},{"key":"ref0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00365.x"},{"key":"ref0015","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.099085"},{"key":"ref0016","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2014-062"},{"key":"ref0017","author":"Bell","year":"2015","journal-title":"Hypertension: The silent killer: Updated JNC-8 guideline recommendations [homepage on the Internet]"},{"key":"ref0018","author":"World Health Organization Global Database on Body Mass Index","year":"2018","journal-title":"World Health Organization Global Database on Body Mass Index [homepage on the Internet]"},{"key":"ref0019","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12446"},{"key":"ref0020","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-143"},{"key":"ref0021","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft010"},{"key":"ref0022","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr702"},{"key":"ref0023","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1832"},{"key":"ref0024","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411050-00009"},{"key":"ref0025","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000040750.40907.99"},{"key":"ref0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00780.x"},{"key":"ref0027","doi-asserted-by":"publisher","DOI":"10.1086\/533468"},{"key":"ref0028","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.13.1581"},{"key":"ref0029","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.19.2560"},{"key":"ref0030","doi-asserted-by":"publisher","DOI":"10.1086\/655681"},{"key":"ref0031","doi-asserted-by":"publisher","DOI":"10.4236\/pp.2014.51015"},{"key":"ref0032","author":"National Department of Health","year":"2015","journal-title":"South African antiretroviral treatment guidelines [homepage on the Internet]"},{"issue":"1","key":"ref0033","first-page":"80","volume":"19","author":"Fabian","year":"2009","journal-title":"Ethn Dis"},{"key":"ref0034","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31815ac4ad"},{"key":"ref0035","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000339"},{"issue":"1","key":"ref0036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1681\/ASN.V81138","volume":"8","author":"D\u2019Agati","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"ref0037","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014050469"},{"key":"ref0038","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60616-X"}],"container-title":["Southern African Journal of HIV Medicine"],"original-title":[],"link":[{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/770\/1149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/770\/1148","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/770\/1150","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/770\/1147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/770\/1147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:08:50Z","timestamp":1660903730000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/view\/770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,19]]}},"URL":"https:\/\/doi.org\/10.4102\/sajhivmed.v19i1.770","relation":{},"ISSN":["2078-6751","1608-9693"],"issn-type":[{"value":"2078-6751","type":"electronic"},{"value":"1608-9693","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,12]]}}}